These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2619278)

  • 21. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of doripenem against anaerobic bacteria].
    Dubreuil L; Neut C; Mahieux S; Muller-Serieys C; Jean-Pierre H; Marchandin H; Soussy CJ; Miara A
    Pathol Biol (Paris); 2011 Apr; 59(2):102-7. PubMed ID: 20537808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M; Baysal B
    Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.
    Shungu DL; Weinberg E; Cerami AT
    J Clin Microbiol; 1985 Jun; 21(6):875-9. PubMed ID: 3859487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):784-6. PubMed ID: 7802861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of HMR 3647 against anaerobic bacteria.
    Edlund C; Sillerström E; Wahlund E; Nord CE
    J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE; Hagelbäck A
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic sensitivity testing of anaerobic bacteria by the breakpoint method.
    Höffler U; Pulverer G
    Chemotherapy; 1984; 30(6):392-7. PubMed ID: 6518836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.
    Wexler HM; Molitoris D; Finegold SM
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2222-4. PubMed ID: 10898709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.
    Dubreuil L; Devos J; Neut C; Romond C
    Antimicrob Agents Chemother; 1984 Jun; 25(6):764-6. PubMed ID: 6742819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
    Hoellman DB; Kelly LM; Credito K; Anthony L; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Jan; 46(1):220-4. PubMed ID: 11751138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM; Finegold SM
    Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds.
    Spiegel CA
    Antimicrob Agents Chemother; 1987 Feb; 31(2):249-52. PubMed ID: 3566250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.